Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2006-05-22 14:17:36 UTC |
---|
Update Date | 2021-10-13 04:37:29 UTC |
---|
HMDB ID | HMDB0002096 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 3-Indolebutyric acid |
---|
Description | 3-Indolebutyric acid is an indolic tryptophan metabolite occasionally found in human urine. (PMID:7130309 ). 3-Indolebutyric acid is a plasma and urinary tryptophan-related metabolite related to metabolic and skin diseases. (PMID:15206797 ). Plasma levels of tryptophan metabolites in the umbilical vein and artery are significantly higher than those in the maternal vein. (PMID:1506727 ). 3-Indolebutyric acid has been shown to accelerated glucose uptake in the rat diaphragm. (PMID:6025019 ). 3-Indolebutyric acid is also a microbial netabolite, urinary indole-3-butyrate is produced by Clostridia sp. (PMID:6630445 ). |
---|
Structure | OC(=O)CCCC1=CNC2=C1C=CC=C2 InChI=1S/C12H13NO2/c14-12(15)7-3-4-9-8-13-11-6-2-1-5-10(9)11/h1-2,5-6,8,13H,3-4,7H2,(H,14,15) |
---|
Synonyms | Value | Source |
---|
1H-Indole-3-butanoic acid | ChEBI | 3-Indolyl-gamma-butyric acid | ChEBI | 4-(indol-3-yl)Butyric acid | ChEBI | 4-indol-3-Ylbutyric acid | ChEBI | IBA | ChEBI | Indole-3-butanoic acid | ChEBI | Indolebutyric acid | ChEBI | Seradix | ChEBI | Indole-3-butyric acid | Kegg | 1H-Indole-3-butanoate | Generator | 3-Indolyl-g-butyrate | Generator | 3-Indolyl-g-butyric acid | Generator | 3-Indolyl-gamma-butyrate | Generator | 3-Indolyl-γ-butyrate | Generator | 3-Indolyl-γ-butyric acid | Generator | 4-(indol-3-yl)Butyrate | Generator | 4-indol-3-Ylbutyrate | Generator | Indole-3-butanoate | Generator | Indolebutyrate | Generator | Indole-3-butyrate | Generator | 3-Indolebutyrate | Generator | Indolebutyric acid, monoammonium salt | MeSH | Indolebutyric acid, monopotassium salt | MeSH | Indolebutyric acid, monosodium salt | MeSH | 1H-Indole-3-butyrate | HMDB | 1H-Indole-3-butyric acid | HMDB | 3-Indole butyrate | HMDB | 3-Indole butyric acid | HMDB | 3-Indolylbutyric acid | HMDB | 3-Iodolebutyrate | HMDB | 4-(1H-indol-3-yl)-Butyrate | HMDB | 4-(1H-indol-3-yl)-Butyric acid | HMDB | 4-(1H-indol-3-yl)Butanoate | HMDB | 4-(1H-Indol-3-yl)butanoic acid | HMDB | 4-(3-1H-Indolyl)butyrate | HMDB | 4-(3-1H-Indolyl)butyric acid | HMDB | 4-(3-Indole)-butyrate | HMDB | 4-(3-Indole)-butyric acid | HMDB | 4-(3-Indolyl)butyrate | HMDB | 4-(3-Indolyl)butyric acid | HMDB | 4-(Indolyl)- butyrate | HMDB | 4-(Indolyl)- butyric acid | HMDB | 4-indol-3-Ylbutyric-acid | HMDB | b-Indolebutyrate | HMDB | b-Indolebutyric acid | HMDB | beta-Indolebutyrate | HMDB | beta-Indolebutyric acid | HMDB | Indole 3-butyrate | HMDB | Indole 3-butyric acid | HMDB | Indole-3 butyrate | HMDB | Indole-3 butyric acid | HMDB | Indole-3-butrylate | HMDB | Indole-3-butrylic acid | HMDB | Indolyl-3-butyrate | HMDB | Indolyl-3-butyric acid | HMDB | 3-Indolebutyric acid | ChEBI | 4-(1H-Indol-3-yl)butyric acid | HMDB | 4-(3-Indolyl)butanoic acid | HMDB | 4-(Indol-3-yl)butanoate | HMDB | [3-(3-Indolyl)propyl]carboxylic acid | HMDB | beta-IBA | HMDB | beta-Indolylbutyric acid | HMDB | gamma-(Indol-3-yl)butyric acid | HMDB | gamma-(Indole-3)-butyric acid | HMDB | β-IBA | HMDB | β-Indolebutyric acid | HMDB | β-Indolylbutyric acid | HMDB | γ-(Indol-3-yl)butyric acid | HMDB | γ-(Indole-3)-butyric acid | HMDB |
|
---|
Chemical Formula | C12H13NO2 |
---|
Average Molecular Weight | 203.2371 |
---|
Monoisotopic Molecular Weight | 203.094628665 |
---|
IUPAC Name | 4-(1H-indol-3-yl)butanoic acid |
---|
Traditional Name | 3-indolebutyric acid |
---|
CAS Registry Number | 133-32-4 |
---|
SMILES | OC(=O)CCCC1=CNC2=C1C=CC=C2 |
---|
InChI Identifier | InChI=1S/C12H13NO2/c14-12(15)7-3-4-9-8-13-11-6-2-1-5-10(9)11/h1-2,5-6,8,13H,3-4,7H2,(H,14,15) |
---|
InChI Key | JTEDVYBZBROSJT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 3-alkylindoles. 3-Alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Indoles |
---|
Direct Parent | 3-alkylindoles |
---|
Alternative Parents | |
---|
Substituents | - 3-alkylindole
- Substituted pyrrole
- Benzenoid
- Pyrrole
- Heteroaromatic compound
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Azacycle
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxide
- Carbonyl group
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 124.5 °C | Not Available | Boiling Point | 426.56 °C. @ 760.00 mm Hg (est) | The Good Scents Company Information System | Water Solubility | 0.25 mg/mL at 20 °C | Not Available | LogP | 2.30 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
3-Indolebutyric acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC1=C[NH]C2=CC=CC=C12 | 2140.6 | Semi standard non polar | 33892256 | 3-Indolebutyric acid,1TMS,isomer #2 | C[Si](C)(C)N1C=C(CCCC(=O)O)C2=CC=CC=C21 | 2196.4 | Semi standard non polar | 33892256 | 3-Indolebutyric acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC1=CN([Si](C)(C)C)C2=CC=CC=C12 | 2168.8 | Semi standard non polar | 33892256 | 3-Indolebutyric acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC1=CN([Si](C)(C)C)C2=CC=CC=C12 | 2114.8 | Standard non polar | 33892256 | 3-Indolebutyric acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC1=CN([Si](C)(C)C)C2=CC=CC=C12 | 2343.5 | Standard polar | 33892256 | 3-Indolebutyric acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC1=C[NH]C2=CC=CC=C12 | 2393.6 | Semi standard non polar | 33892256 | 3-Indolebutyric acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=C(CCCC(=O)O)C2=CC=CC=C21 | 2435.6 | Semi standard non polar | 33892256 | 3-Indolebutyric acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC=C12 | 2617.8 | Semi standard non polar | 33892256 | 3-Indolebutyric acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC=C12 | 2557.0 | Standard non polar | 33892256 | 3-Indolebutyric acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC=C12 | 2559.8 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - 3-Indolebutyric acid GC-MS (1 TMS) | splash10-000x-0910000000-7c2b4d74ecedb117caf3 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 3-Indolebutyric acid GC-MS (2 TMS) | splash10-0udi-0391000000-c62444bc1faa5f67d652 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 3-Indolebutyric acid EI-B (Non-derivatized) | splash10-001i-0920000000-a53e6a97ea38d50751b7 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 3-Indolebutyric acid GC-MS (Non-derivatized) | splash10-000x-0910000000-7c2b4d74ecedb117caf3 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 3-Indolebutyric acid GC-MS (Non-derivatized) | splash10-0udi-0391000000-c62444bc1faa5f67d652 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Indolebutyric acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-005c-2900000000-6403d086e6b2ec4ac0d3 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Indolebutyric acid GC-MS (1 TMS) - 70eV, Positive | splash10-05j0-7920000000-fc57e474504223a4e838 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Indolebutyric acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-0f79-0970000000-7543d99fe8a1f2b0de25 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-00lu-0900000000-b46d8f64c372b7348dbd | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-00lu-2900000000-ccb02800c683b0a921ee | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid EI-B (HITACHI M-68) , Positive-QTOF | splash10-001i-0920000000-a53e6a97ea38d50751b7 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-0udi-0090000000-d6f784c6fec287fbd7c4 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-0udi-0590000000-22d2baa6bbf6262cb3cf | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-014i-1900000000-21352951c1447c77df39 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-014i-2900000000-184013bb3b879000bdf1 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-014i-2900000000-cd1951f573aa0d883a8c | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-0f79-1930000000-d04d53f6788d45ef881f | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-002u-2900000000-e52b6e60b86d650a9c2e | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-0032-8900000000-f17437c2c96f7f7f4ed2 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-017j-9500000000-8e79159a3b4ebf3488d8 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-014i-5900000000-afb8479ad9268699e823 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ , negative-QTOF | splash10-0udi-0090000000-d6f784c6fec287fbd7c4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ , negative-QTOF | splash10-0udi-0590000000-22d2baa6bbf6262cb3cf | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ , negative-QTOF | splash10-014i-1900000000-21352951c1447c77df39 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ , negative-QTOF | splash10-014i-2900000000-184013bb3b879000bdf1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Indolebutyric acid LC-ESI-QQ , negative-QTOF | splash10-014i-2900000000-cd1951f573aa0d883a8c | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Indolebutyric acid 10V, Positive-QTOF | splash10-0udr-0960000000-cbabcf60da67d36a7a52 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Indolebutyric acid 20V, Positive-QTOF | splash10-0pbl-2910000000-66aadf35b92473e5d20e | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Indolebutyric acid 40V, Positive-QTOF | splash10-0006-5900000000-3eb3c75b1c9c299f55b5 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Indolebutyric acid 10V, Negative-QTOF | splash10-0udi-0290000000-534678e83a3a049ca362 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Indolebutyric acid 20V, Negative-QTOF | splash10-0zfr-1890000000-baeca4f8b84a743b76a0 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Indolebutyric acid 40V, Negative-QTOF | splash10-0a4l-9700000000-72990cf325b9dadb784a | 2017-07-26 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, Methanol, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Membrane (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Schizophrenia | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Schizophrenia |
---|
- Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26. [PubMed:22800120 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB02740 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB001404 |
---|
KNApSAcK ID | C00000116 |
---|
Chemspider ID | 8298 |
---|
KEGG Compound ID | C11284 |
---|
BioCyc ID | CPD-10507 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Indole-3-butyric_acid |
---|
METLIN ID | 6485 |
---|
PubChem Compound | 8617 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 33070 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | rw1190841 |
---|
References |
---|
Synthesis Reference | Polaczkowa, W.; Porowska, N. 3-Indolebutyric acid. Przemysl Chemiczny (1950), 6 340-3. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Merle M, Gilbert A, Fredenucci JF, Petry D, Foliguet B, Mosnier M: Experimental and clinical study of the effect of naftidrofuryl on the recovery from peripheral nerve lesions. Microsurgery. 1994;15(3):179-86. [PubMed:8015423 ]
- Hirsch JL, Bensoussan JJ, Mosnier M, Lehert P: [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study]. Ann Cardiol Angeiol (Paris). 1999 Feb;48(2):137-45. [PubMed:12555338 ]
- Meininger V, Chaineau E, Soudiere B: [Effect of naftidrofuryl (LS129) on axonal growth]. Rev Neurol (Paris). 1994;150(2):115-22. [PubMed:7863151 ]
- Eguchi K, Kamimura S, Yonezawa M, Mitsui Y, Mizutani Y, Kudo T: [Tryptophan and its metabolite concentrations in human plasma during the perinatal period]. Nihon Sanka Fujinka Gakkai Zasshi. 1992 Jun;44(6):663-8. [PubMed:1506727 ]
- Tonelli D, Gattavecchia E, Gandolfi M: Thin-layer chromatographic determination of indolic tryptophan metabolites in human urine using Sep-Pak C18 extraction. J Chromatogr. 1982 Sep 10;231(2):283-9. [PubMed:7130309 ]
- Marklova E, Albahri Z, Nozickova M: HPLC profiling of Trp-related metabolites in humans. Adv Exp Med Biol. 2003;527:739-44. [PubMed:15206797 ]
- Silverstein MN, Wakim KG, Bahn RC: The influence of tryptophan metabolites on tissue uptake of glucose. Metabolism. 1967 May;16(5):410-2. [PubMed:6025019 ]
- Lombard GL, Dowell VR Jr: Comparison of three reagents for detecting indole production by anaerobic bacteria in microtest systems. J Clin Microbiol. 1983 Sep;18(3):609-13. [PubMed:6630445 ]
|
---|